EMAã«ããå°å çšCOVIDã¯ã¯ãã³ã®æ¿èªä»¥éãæ¬§å·å šåã§å°å ã®éå°æ»äº¡ã632åã«å¢å ããããšã確èªããå ±åæž
å èšäºã¯ãã¡ããã/Click here to read the original article.
2021幎ã®çŒç±ã®å€ãéå€§ãªæ±ºå®ããšãŒãããå šåãé§ãå·¡ãã24æé365æ¥ã®ãããã¬ã³ãã«èžããããåäŸãã¡ã«åžæã®å ãåŸ ã¡æãã§ãã芪ãã¡ã®éã«ææ ã®æžŠãå·»ãèµ·ãããã
欧å·å»è¬ååºïŒEMAïŒãã€ãã«ããã¡ã€ã¶ãŒã®COVID-19ã¯ã¯ãã³ã®12æ³ãã15æ³ã®åäŸãžã®ç·æ¥äœ¿çšãæ¿èªããã®ã ã
ããã¯ãã³ãããã¯ïŒäžçç倧æµè¡ïŒãé²ãå
æã§ãããšèããç¡æ°ã®çŽ æŽãªèŠªãã¡ã®èžã«ãå®å µãšé«æãæŒãå¯ããã
ããããåäŸãã¡ãžã®ã¯ã¯ãã³æ¥çš®ãå§ãŸããšã幞éã®é¢šã¯æãããããªãæ¹åã«åãã£ããé©ãã¹ãå ±åæžãçºè¡šããã倧éžå
šåã§å¹ŒãåäŸãã¡ã®éå°æ»äº¡ãæ¥å¢ããŠããããšãæããã«ãªã£ãã®ã ã圱é¿ãåããäœåãã®å®¶æã®éã§ã¯ã楜芳çãªæèŠã¯ããã«æ¶ãå»ããå€ãã®äººã
ã®åžæã«åœ±ãèœãšãå³ããçŸå®ã«åã£ãŠä»£ããããã
2023幎ã®ç¬¬22é±ãŸã§ã«ã0æ³ãã14æ³ãŸã§ã®åã©ãã®éå°æ»äº¡çã63,060ïŒ
ãšããé©ç°çãªæ°åãèšé²ããã®ã ããã®æ°åã¯ãå€ãã®äººã
ãæ²é»ããå³ããæ€é²ããã声ã«ãã£ãŠäºèŠãããçµæ«ããå·ãããã«åããŠããã
2020å¹Žåœæããã³ãããã¯ïŒäžçç倧æµè¡ïŒã«å¯Ÿããã¯ã¯ãã³ã«èŠããããmrnaæè¡ã®å©çšãæ©æ¥ã«é²ããããšå¿ æ»ã ã£ãäœå¶åŽã«ãšã£ãŠãCOVID-19泚å°å€ã¯ãŸã éçºã®èèœæ®µéã«ãããèŠå¶åœå±ã®æ¿èªã«åããäžå®å®ãªéãæ©ãã§ããã
ãã®å ¥æãæ©ãããããæ¬§å·å»è¬ååºïŒEMAïŒãç±³åœé£åå»è¬åå±ïŒFDAïŒãšãã£ãèŠå¶æ©é¢ã¯ç·æ¥äœ¿çšèš±å¯ïŒEUAïŒãçºåãããã®æ¬æ°ã§å±éºãªã¯ã¯ãã³ã«äžæçãªåœç¶±ãäžããã
ãããã®EUAã¯ããã³ãããã¯ïŒäžçç倧æµè¡ïŒã®ãããªæ²æšãªç¶æ³äžã«ãããŠãèŠå¶åœå±ã®æ¿èªãšããå³ããããã»ã¹ãçµãåã§ãã£ãŠããå»è¬åã®äœ¿çšãèš±å¯ããèŠå¶ã¡ã«ããºã ãšããŠæ©èœããã
åäŸã®ãªã屿©ã«çŽé¢ãããšãã«ãšãããåäŸã®ãªãæªçœ®ã ã£ããããããCovid-19ã®ãã³ãããã¯çæã¯ãåã©ããã¡ãžã®è åšã§ã¯ãªãããšã蚌æããããããã®èŠå¶æ©é¢ã«ããä»åŸã®æ±ºå®ã¯æ¥µããŠçããããã®ãšãªããç¯çœªçãªãã®ã«ãªãå¯èœæ§ããã£ãã
2020幎12æãŸã§mRNAã¯ã¯ãã³ãäžè¬éå£ã«åºãæ¡çšãããªãã£ã決å®çãªçç±ã®ã²ãšã€ã¯ãæäœäŸåæ§å¢åŒ·ïŒADEïŒã®ææã§ãã£ãã
ãã®çŸè±¡ã¯ãmRNAã¯ã¯ãã³ã«ããã¯ã¯ãã³æ¥çš®ãç æ°ãæªåãããæ¥çš®ããã人ã ãããç æ°ã«ãããããããªãå¯èœæ§ããããšããæžå¿µãåŒãèµ·ãããç§åŠçèšèª¬ã®å»äžã«åºæ²¡ããã
ãã³ã°ç±ã¯ã¯ãã³ã®éçºã«ãããŠãADEã¯ãã§ã«æŽå²ã«æ®ãæããããšããœãŒããç®æããŠãããåæã®èšåºè©Šéšã§ã¯ãéå»ã«ææããããšã®ãªã人ã«ã¯ãŠã€ã«ã¹ã«å¯Ÿããé²åŸ¡å¹æãèªããããææã§ããããšã瀺ãããã
ãããæ²ããããšã«ã以åã«ç°ãªãæ ªã®ãŠã€ã«ã¹ã«ææããããšã®ããæ£è ã§ã¯ãã¯ã¯ãã³ã¯éçåã®ãªã¹ã¯ãå¢å¹ ãããããã§ãã£ãã
å€ãã®åç©å®éšã§ããæœåšç㪠"ã¯ã¯ãã³ "ãããã®åŸãŠã€ã«ã¹ã«æŽé²ãããéã«èºã®ççããã®ä»ã®å¯äœçšãèªçºãããã¯ã¯ãã³ã«ãã£ãŠèªçºãããå ç«åå¿ã¯ããŠã€ã«ã¹ãäžåããã©ããããèºçµç¹ã«å€§æ··ä¹±ãåŒãèµ·ãããäºæãã¬çµæã®çè·¡ãæ®ããã
ããã«ãã³ãããŠã€ã«ã¹ã«å¯Ÿãããã®ãå«ããåŒåžåšç³»ãŠã€ã«ã¹ã¯ã¯ãã³ã®èšåºè©Šéšã§ã¯ãã¯ã¯ãã³é¢é£çŸæ£ïŒVAEDïŒã®äžåãªäºå ã倧ããç«ã¡ã¯ã ãã£ãã
äŸãã°ãåŒåžåšåèäœãŠã€ã«ã¹ïŒRSVïŒã¯ã¯ãã³ã®èšåºè©Šéšã§ã¯ãã¯ã¯ãã³æ¥çš®ãåãã乳幌å ããŠã€ã«ã¹ã«ééãããšå ¥é¢ã®ãªã¹ã¯ãé«ãŸããåŒåžåšçŸæ£ãéçåãããšããäžç©ãªãã¿ãŒã³ãæããã«ãªã£ãã
ã¯ã¯ãã³ã«ãã£ãŠåŒãèµ·ããããå ç«åå¿ã¯ããŠã€ã«ã¹ãé²ããšãããããããããå ç«ç³»ã®éå°åå¿ãåŒãèµ·ãããç æ°ã®çç¶ãæªåãããããã§ãã£ãã
ã³ãããŠã€ã«ã¹ãRSVã®ãããªåŒåžåšç³»ãŠã€ã«ã¹ã¯ãç¹ã«ä¹³å¹Œå ãé«éœ¢è ãšãã£ã瀟äŒç匱è ã«ãšã£ãŠé倧ãªè åšã§ããããšã¯ä»¥åããèªèãããŠããã
ããããCOVID-19ã®ãã³ãããã¯ãåŒãèµ·ããããšãããSARS-CoV-2ãŠã€ã«ã¹ã¯ãè¥ãäžä»£ãå ããŠããããã«èŠããCOVID-19ã¯ã¯ãã³æ¥çš®ã®ç·æ¥æäœ¿çšèš±å¯ïŒEUAïŒã®å°å ãžã®æ¡å€§ã«ã€ããŠäžå¯è§£ãªåé¡ãæèµ·ããã
åã©ããã¡ã«å·®ãè¿«ã£ãè åšããªãã£ãããšããæææ±ºå®ããã»ã¹ãããã«æ··ä¹±ãããã
æçµçãªç®æšã¯å°ã蟌ãã§ã¯ãªãã£ãã¯ãã§ãããå®éã®ããŒã¿ããç®èãªããšã倿ããã®ã ããŠã€ã«ã¹ãã身ãå®ãããã®çŸãããã®äœ¿åœãæãããªãã£ãã®ã§ããã
ç®ãèŠåŒµããããªã°ã©ãã¯ã2022幎1æ3æ¥ãã3æ27æ¥ãŸã§ã®æéã§ãã€ã³ã°ã©ã³ãã«ãããã¯ã¯ãã³æ¥çš®ã®æç¡ãšå¹Žéœ¢å±€å¥ã«åé¡ãããCovid-19ã®ç·çäŸæ°ãå ¬è¡šããŠããããã®ããŒã¿ã¯ãè±åœå¥åº·å®å šä¿éå±ïŒUKHSAïŒã®ç¬¬5é±ïŒ43ããŒãžïŒã第9é±ïŒ41ããŒãžïŒã第13é±ïŒ41ããŒãžïŒã®ã³ãã19ã¯ã¯ãã³ã»ãµãŒãã€ã©ã³ã¹ã»ã¬ããŒãããæç²ããããã®ã§ãäžç©ãªçŸå®ãé®®æã«æãåºããŠããã

åæ§ã«ãã€ã³ã°ã©ã³ãã«ãããã¯ã¯ãã³æ¥çš®ã®æç¡ãšå¹Žéœ¢å±€å¥ã«ã人å£10äžäººåœããã®çœ¹æ£çã瀺ããã°ã©ãããããé©ãã¹ãæ Œå·®ãæµ®ãã³äžãã£ãŠãããã©ã®å¹Žéœ¢å±€ã«ãããŠãã3皮混åã¯ã¯ãã³ãæ¥çš®ãã人ã ã®éã§çœ¹æ£çãæ¥äžæããŠãããã¯ã¯ãã³æªæ¥çš®ã®äººã ãšã®éã«ã¯å€§ããªéããããã£ãã
ãã®æºã¯æéãçµã€ã«ã€ããŠåºããã°ããã§ãã£ãã

ãã®æ°åãç©èªã£ãŠããã®ã¯ãã³ããã19ã¯ã¯ãã³ãæ¥çš®ãã人ã¯ãã¯ã¯ãã³ãæ¥çš®ããŠããªãäººã«æ¯ã¹ãŠææãªã¹ã¯ãé«ããšããããšã§ããããã®èšŒæ ã«ããã詳现ãªèª¿æ»ãå¿ èŠã ã£ãã
ãããããã®æ€èšŒã¯ããŸã ã«è¡ãããŠããªããæ²ããããšã«ããšãŒããã諞åœã®å ¬åŒçµ±èšããŒã¿ãåèšããŠããçµç¹ã§ããEuroMOMOã¯ãæè¿ã®åæã§ããã¡ã€ã¶ãŒç€Ÿã®å°å çšã¯ã¯ãã³COVID-19ã®æ¿èªãšè¥å¹Žå±€ã®éå°æ»äº¡ã®æ¥å¢ãšã®éã«æ²æšãªçžé¢é¢ä¿ãããããšãæããã«ããããŒã¿ãçºè¡šããã
ãŠã¯ã©ã€ããé€ããšãŒããã26ã«åœã®åå åœããåéããããã®ããŒã¿ã¯ãç¡èŠã§ããªãæ²æšãªç¶æ³ãæãåºããŠããã
2023幎第22é±ãŸã§ã®ãŸããšãããããªæ°åã¯ãééããªãé¢ä¿è ã®æ³šç®ãéããã ããã
ãŸãããã®ããŒã¿ã¯ãšãŒããã44ã«åœã®ãã¡ããŠã¯ã©ã€ããé€ã26ã«åœã察象ãšããŠãããã€ãŸãããã®èª¿æ»çµæãçŸåšé²è¡äžã®æŠäºã«èµ·å ãããšã®äž»åŒµã¯ãå³åº§ã«éãããããšããããšã ã
2021幎第21é±ã欧å·å»è¬ååºã¯ãã¡ã€ã¶ãŒç€Ÿè£œã¯ã¯ãã³COVID-19ã®ç·æ¥äœ¿çšèªå¯ãæ¡å€§ããã


ããããæ¿èªåŸã®æ°é±éã¯ãåã©ããã¡ã®éå°æ»äº¡ãè¡æçã«å¢å ãããã®å¢å åŸåã¯æ¢ãŸããªãã£ãã
2021幎第22é±ãã第52é±ã®éã«ã0æ³ãã14æ³ã®åã©ããã¡ã®éã§919人ã®éå°æ»äº¡ãçºçãã倧éžã«è¡æãèµ°ãã¯ãã ã£ããããããããŒã¿ã¯é èœãããã
2021幎第1é±ãã第21é±ãŸã§ã®æ»äº¡è æ°ã¯äºæ³ãã218人å°ãªãã£ãããã§ããã

ãããŠãéå°æ»äº¡ã®æ¥å¢ãEMAã«ãã12æ³ãã15æ³ã®å°å ã察象ãšãããã¡ã€ã¶ãŒç€Ÿè£œCOVID-19ã¯ã¯ãã³ã®æ¿èªãšå®å šã«äžèŽããŠãããšããäºå®ã¯ãåãªãå¶ç¶ãšããŠçä»ããããšã¯ã§ããªãã
ãã®æ²æšãªåŸåã¯2022幎ãéããŠç¶ããæ¬§å·26ã«åœã§0æ³ãã14æ³ãŸã§ã®åèš1,639人ãéå°æ»äº¡ããŠãããçéã§ããªãå³ããçŸå®ãæãåºããŠããã

æ²ããããšã«ã2023幎第22é±ãè¿ãããšãããã«590人ãåèš3,148人ã®åäŸãã¡ãæ»äº¡ããã

ãã®æ²çãªæ°åã¯ã欧å·å»è¬ååºïŒEEAïŒãã³ããã19ã¯ã¯ãã³ã®ç·æ¥äœ¿çšèš±å¯ã12æ³ãã15æ³ã®å°å ã«ãŸã§æ¡å€§ããŠä»¥æ¥ãéå°æ»äº¡ãåäŸã®ãªã63,060ïŒ ã«æ¥å¢ããããšãç©èªã£ãŠããã
以åãšã®å¯Ÿç §ã¯ãã以äžãªãã»ã©é®®æã§ããã

2019幎第21é±ãã2021幎第21é±ãŸã§ã0æ³ãã14æ³ã®åã©ãã®æ»äº¡æ°ã¯äºæ³ãã5人å°ãªãã£ãã

2020å¹Žå šäœã§ã¯ãæ»è æ°ãäºæ³ãã230人å°ãªããšããé¡èãªæžå°ãèŠãããå·ããããªç©èªãæãããŠããã

äžæ¹ã欧å·å šåã§å°å çšã³ããã-19泚å°å€ã®ç·æ¥äœ¿çšãæ¿èªãããåã®2021幎第21é±ãŸã§ã®æ»äº¡è æ°ã¯ãäºæ³ãã218人å°ãªãã£ãã

è±åœããã©ã³ã¹ãã¹ãã€ã³ãã€ã¿ãªã¢ããã€ããå«ããšãŒããã26ã«åœã®0æ³ãã14æ³ã®åã©ããã¡ã®éå°æ»äº¡ã®é©ç°çãªå¢å ã¯ã欧å·å»è¬ååºããã¡ã€ã¶ãŒç€Ÿè£œCOVID-19ã¯ã¯ãã³ã®ç·æ¥äœ¿çšæ¿èªã12æ³ãã15æ³ã®åã©ããã¡ãŸã§å»¶é·ããŠä»¥æ¥ã63,060ïŒ ãšããé©ç°çãªæ¥å¢ãšããæãçµµãæããŠããã

ãã®æ²æšãªçŸå®ã¯ã泚å°ã®å®éšçæ§è³ªããæäœäŸåæ§å¢åŒ·çïŒADEïŒãã¯ã¯ãã³é¢é£å¢åŒ·çïŒVAEDïŒã®ãªã¹ã¯ã®ããã«ãããŸã§é¿ããããŠããããšãèæ ®ãããšãæ·±å»ãªæžå¿µãæ±ãããã
ããã«ããã³ãããã¯ãšãããCovid-19ãŠã€ã«ã¹ã«ããé倧ãªãªã¹ã¯ã«ãããããŠããªãå°å ã«ã¯ã¯ãã³ãæäžããããšã¯ããã³ãããã¯çæã®çºçãã幎æ«ãŸã§ã®2020幎ã«ãšãŒãããå šåã§èšé²ããã0æ³ãã14æ³ã®å°å ã®æ»äº¡è æ°ã230人æžå°ããŠããããšã«ç §ãããšãäžå¯è§£ã«æããã

